180 related articles for article (PubMed ID: 29483302)
21. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.
Nolan MK; Jankowska L; Prisco M; Xu S; Guvakova MA; Surmacz E
Int J Cancer; 1997 Sep; 72(5):828-34. PubMed ID: 9311601
[TBL] [Abstract][Full Text] [Related]
22. Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action.
Rabiee A; Krüger M; Ardenkjær-Larsen J; Kahn CR; Emanuelli B
Cell Signal; 2018 Jul; 47():1-15. PubMed ID: 29550500
[TBL] [Abstract][Full Text] [Related]
23. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG
J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348
[TBL] [Abstract][Full Text] [Related]
24. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
[TBL] [Abstract][Full Text] [Related]
25. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
26. Insulin receptor substrate-4 enhances insulin-like growth factor-I-induced cell proliferation.
Qu BH; Karas M; Koval A; LeRoith D
J Biol Chem; 1999 Oct; 274(44):31179-84. PubMed ID: 10531310
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
Tartare-Deckert S; Sawka-Verhelle D; Murdaca J; Van Obberghen E
J Biol Chem; 1995 Oct; 270(40):23456-60. PubMed ID: 7559507
[TBL] [Abstract][Full Text] [Related]
28. Insulin receptor substrate signaling suppresses neonatal autophagy in the heart.
Riehle C; Wende AR; Sena S; Pires KM; Pereira RO; Zhu Y; Bugger H; Frank D; Bevins J; Chen D; Perry CN; Dong XC; Valdez S; Rech M; Sheng X; Weimer BC; Gottlieb RA; White MF; Abel ED
J Clin Invest; 2013 Dec; 123(12):5319-33. PubMed ID: 24177427
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family.
Kaburagi Y; Yamauchi T; Yamamoto-Honda R; Ueki K; Tobe K; Akanuma Y; Yazaki Y; Kadowaki T
Endocr J; 1999 Mar; 46(Suppl):S25-34. PubMed ID: 12054114
[TBL] [Abstract][Full Text] [Related]
30. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.
Myers MG; Sun XJ; Cheatham B; Jachna BR; Glasheen EM; Backer JM; White MF
Endocrinology; 1993 Apr; 132(4):1421-30. PubMed ID: 8384986
[TBL] [Abstract][Full Text] [Related]
31. Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes.
Chuang LM; Myers MG; Seidner GA; Birnbaum MJ; White MF; Kahn CR
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5172-5. PubMed ID: 7685118
[TBL] [Abstract][Full Text] [Related]
32. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
Jackson JG; White MF; Yee D
J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
[TBL] [Abstract][Full Text] [Related]
33. Interaction between nuclear insulin receptor substrate-2 and NF-κB in IGF-1 induces response in breast cancer cells.
Wu S; Zhou B; Xu L; Sun H
Oncol Rep; 2010 Dec; 24(6):1541-50. PubMed ID: 21042750
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
[TBL] [Abstract][Full Text] [Related]
35. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
Brüning JC; Winnay J; Cheatham B; Kahn CR
Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
[TBL] [Abstract][Full Text] [Related]
36. Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells.
Mercado-Matos J; Clark JL; Piper AJ; Janusis J; Shaw LM
J Biol Chem; 2017 May; 292(19):7806-7816. PubMed ID: 28320862
[TBL] [Abstract][Full Text] [Related]
37. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice.
Patti ME; Sun XJ; Bruening JC; Araki E; Lipes MA; White MF; Kahn CR
J Biol Chem; 1995 Oct; 270(42):24670-3. PubMed ID: 7559579
[TBL] [Abstract][Full Text] [Related]
38. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
[TBL] [Abstract][Full Text] [Related]
39. The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.
Sisci D; Morelli C; Cascio S; Lanzino M; Garofalo C; Reiss K; Garcia M; Russo A; Andò S; Surmacz E
Ann Oncol; 2007 Jun; 18 Suppl 6():vi81-5. PubMed ID: 17591841
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
